Analysis of baseline samples suggests that sAng2, CRP, ferritin, IL−6, LDH, and procalcitonin (PCT) were elevated in study participants with worse outcomes independent of treatment assignment, which is consistent with previously reported associations of baseline inflammatory biomarkers and COVID-19 severity18–20. The gene discussed is CRP; the disease is COVID-19.